首页 | 本学科首页   官方微博 | 高级检索  
     

急性心肌梗死静脉尿激酶溶栓后早期应用肝素防止再梗死的临床研究
引用本文:马伟东. 急性心肌梗死静脉尿激酶溶栓后早期应用肝素防止再梗死的临床研究[J]. 中国医药导报, 2011, 8(9): 42-43
作者姓名:马伟东
作者单位:广东省惠州市第一人民医院心内科,广东惠州,516003
摘    要:目的:观察急性心肌梗死静脉尿激酶溶栓后早期应用肝素防止再梗死的临床效果。方法:将104例急性心肌梗死溶栓患者随机分为观察组和对照组,各52例。对照组予以尿激酶;观察组在应用尿激酶前即刻给予肝素5 000 U静脉注射,并于尿激酶给药12 h后监测凝血时间和(或)激活全血凝固时间(ACT),待与治疗前比较其〈1.5倍时,予以肝素皮下注射。结果:观察组再通率为86.54%,对照组再通率为69.23%,两组比较,差异有统计学意义(P〈0.05);观察组血管再通后再梗死率为4.44%,对照组血管再通后再梗死率为19.44%,两组比较,差异有统计学意义(P〈0.05);两组治疗后血清肌酸激酶同工酶水平比较,两组升高趋势比较,观察组明显优于对照组,差异有统计学意义(P〈0.01)。结论:急性心肌梗死静脉尿激酶溶栓后早期应用肝素能够防止血管再闭塞,减少再梗死率,联合用药具有安全、简便、易行的优点。

关 键 词:急性心肌梗死  尿激酶  静脉溶栓  肝素  再梗死

Clinical study on early applying Heparin on preventing re-infarction after intravenous Urokinase thrombolysis of acute myocardial infarction
MA Weidong. Clinical study on early applying Heparin on preventing re-infarction after intravenous Urokinase thrombolysis of acute myocardial infarction[J]. China Medical Herald, 2011, 8(9): 42-43
Authors:MA Weidong
Affiliation:MA Weidong Department of Cardiology,the First People's Hospital of Huizhou City in Guangdong Province,Huizhou 516003,China
Abstract:Objective:To observe the clinical effect of early applying Heparin on preventing further infarction after intravenous Urokinase thrombolysis of acute myocardial infarction.Methods:104 patients with acute myocardial infarction were randomly divided into two groups of 52 cases in observation group and 52 cases in control group respectively.The control group was given with Urokinase;the observation group was immediately given with Heparin 5 000 U intravenous injection before applying Urokinase,the clotting tim...
Keywords:Acute myocardial infarction  Urokinase  Intravenous thrombolysis  Heparin  Re-infarction  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号